MANILA, Philippines — A member of the Diplomate of the Specialty Board of Philippine Psychiatry (DSBPP) has called for an end to the stigma surrounding obesity and urged greater support for ...

(Reuters) -Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.

(Reuters) -Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous ...

One way that obesity is thought to increase the risk of cancer is because adipose (fat) tissue releases inflammatory hormones that can then cause uncontrolled cell growth, Thosani says.

Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the support of Knut and Alice Wallenberg Foundation and Region Västra ...

Since 1975, the number of people with obesity around the world has almost tripled. According to the World Health Organization, this sharp increase is a major health concern.

Globally, obesity is on the rise, and it is projected that without immediate action, around a third (746 million) of the world’s children and adolescents will be overweight or obese by 2050.

Objective Overweight and obesity have been shown to be related to multiple chronic conditions, leading to a heavy economic burden on society throughout the world. This study aims to estimate the ...

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio. Verve’s innovative gene-editing technology, which permanently ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II diabetes (T2D) and Wegovy for obesity. Ozempic and Wegovy include the same ...

Dive Brief: A medicine developed to treat a genetic muscle-wasting disease can improve results for patients taking GLP-1 weight-loss medicines, according to a new Phase 2 study. Scholar Rock has ...